PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportssmall cell carcinoma
MeSH D018288 - small cell carcinoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002277:Carcinoma
18 Companies
3 Drugs
$
Success rate
D018288: 
Small cell carcinoma
20 Companies
3 Drugs
$
Success rate
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaTopotecan Topotecan Teva  2009-09-21   
Cisplatin Cisplatin  2000-05-16   
Novast LaboratoriesTopotecan Topotecan  2016-11-30   
Rising PharmaceuticalsTopotecan Topotecan  2012-08-28   
SandozTopotecan Hycamtin  1996-05-28   
Topotecan Topotecan  2011-02-25   
PfizerTopotecan Topotecan Hospira  2010-06-09   
Dr Reddys LaboratoriesTopotecan Topotecan  2011-03-09   
Sun Pharmaceutical IndustriesTopotecan Topotecan  2013-08-29   
HospiraTopotecan Topotecan  2011-02-02   
Accord HealthcareTopotecan Topotecan  2013-06-26   
Cisplatin Cisplatin  2015-08-18   
Smithkline BeechamTopotecan Evotopin  1997-04-15   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
75%
18/24
Phase 2
11%
5/44
Phase 3
33%
3/9
Approved: 2Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cisplatin
Pfizer
Topotecan,
Bevifimod,
Pf00299804
Accord Healthcare
Cisplatin
Smithkline Beecham
Topotecan
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use